Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis in young children. Microbial agents such as endotoxin and RSV are implicated in airway inflammation during the development of reactive airway disease (RAD) later in childhood. Toll-like receptors (TLRs) are involved in an inflammation cascade through pathogen-associated molecular pattern recognition including lipopolysaccharide (LPS) and viral components. In this study, we investigated the expression of TLRs and cytokine-chemokine production profiles of RSV-infected epithelial cells. In live-RSV infected human tracheal epithelial cell line (9HTEo), TLRs 1-10 mRNA levels were up-regulated in a time-dependent manner compared with ultraviolet (UV)-inactivated RSV. RSV was shown to alter TLR4 membrane and cytosolic location in epithelial cells. Stimulating RSV-infected epithelial cells with TLR4 agonist LPS increased synthesis of IL-6, IL-8, and reduced regulated on activation, normal T cell expressed and secreted (RANTES) production. TLR4 neutralizing antibody HTA125 and TLR4-targeting RNA interference experiments revealed that TLR4 signaling pathway played a predominant role in mediating LPS-induced-IL-6 production of RSV infected epithelial cells. Altogether, our studies indicated that TLR4 play a critical role in leading LPS mediated-IL-6 response in RSV infected-epithelial cells and might be an important factor influencing the cytokine-chemokine profile of epithelial cells interacting with virus and endotoxin, which is correlated with phenotypes of RSV diseases. (Pediatr Res 65: 156-162, 2009) 
R espiratory syncytial virus (RSV) is the major cause of
lower respiratory tract disease in infants and young children worldwide. Children who have recovered from RSV bronchiolitis are at increased risks to reactive airway disease (RAD) such as recurrent wheezing or persistent wheezing in later childhood. Although there is increasing evidence that the host response to RSV infection is a combined function of genetic background, exposure to environmental antigens, the degree of maturation of the host's immune system and airway at the time of the infection (1), the mechanisms and signaling pathways of RSV-induced RAD are still not completely understood.
Mammalian toll-like receptors (TLRs), homologues of Drosophila Toll proteins are indispensable molecules at recognizing the pathogen-associated molecular pattern (PAMP) of invasive agents (2) (3) (4) . One of the most fundamental TLRmediated effects is to activate NF-B members and monitor subsequent proinflammatory cytokines or chemokines production, which are strongly associated with the outcome of inflammatory disease. As a member of the Paramyxoviridae family, RSV consists of a negative-strand RNA genome in a nucleocapsid surrounded by one envelope, and a number of TLRs are supposed to recognize these components, including TLR3 (double-stranded RNA), TLR4 (binding to F-protein of RSV), TLR7/8 (single-stranded RNA), and TLR9 (DNA as unmethylated CpG motif) (5) (6) (7) (8) .
Respiratory epithelium has emerged as a major origin of airway inflammation, because it is the primary site for RSV entry and replication. A new paradigm called the Epithelial -ViralAllergic, formally presented by Holtzman et al. (9) , has described the important roles of airway epithelium, paramyxovirus and allergen in airway inflammation. Cytokines and chemokines, secreted by airway epithelial cells, play a critical role in regulating local inflammatory processes in the lung and may arise as a result of excessive activation of TLRs by pathogen recognition. Some studies have found that TLR1-10 are constitutively expressed in the respiratory epithelial cells (2,10 -12) , and Monick et al. (13) reported that RSV could sensitize airway epithelial cells to endotoxin exposure by releasing IL-8 through TLR4 pathway, although un-infected epithelial cell were quite tolerant to lipopolysaccharide (LPS) challenge.
In this study, we evaluated the effect of RSV on TLR1-10 mRNA expression in tracheal epithelial cells and determined the relevance of epithelial TLR4 in mediating inflammation in the RSV-LPS co-existing system. RSV induces epithelialdependent IL-8, IL-6, and regulated on activation, normal T cell expressed and secreted (RANTES) secretion in its acute state (14) , and we hypothesized that the cytokine-chemokine secretion profile of epithelial cells, characterized by RSVinduced TLR4 signaling pathway leading to IL-6 response after endotoxin exposure, might be an important aspect in RSV-induced RAD according to the possible pathogenesis.
METHODS
Epithelial cell culture. The human tracheal epithelial cell line (9HTEo) was derived from human tracheal epithelium and received as a gift from Professor Hans D. Ochs (University of Washington School of Medicine, Seattle, Washington). It was grown as a monolayer in RPMI 1640 (GIBCO, USA), supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 U/mL penicillin, 100 g/mL streptomycin at 37°C with 5% CO 2 in humidified air. Endotoxin contamination of the media used in subsequent experiments was below 0.25 ng/mL.
RSV propagation and titer determination. Viral stock of human RSV A2-strain was obtained from Viral Laboratory in Beijing Children's Hospital (Capital University of Medical Sciences, Beijing, China). RSV and ultraviolet (UV) light-inactivated RSV was prepared as previously described (13) . Multiplicity of infection (MOI) was 10 in the subsequent experiments.
Quantification of toll-like receptor 1-10 RNA by RT-PCR and Real-Time Quantitative PCR. Cells (ϳ2.5 ϫ 10 5 ) were harvested at 3, 6, and 9 h post RSV infection and total RNA was extracted by TRIzol Reagent (Invitrogen Life Technologies, USA). Reverse transcription was performed as previously described (15) . First, standard PCR was performed in a total volume of 25 L and PCR conditions were 63°C for 60 s for 39 cycles. Second, synthesized cDNA was diluted (1:10) and quantified by real-time PCR using the Taqman Technology (Applied Biosystems, CA) as described previously (15) . The ␤-actin gene was amplified as an internal control. Standard curves were generated using serial dilutions of plasmids (ϳ10 -10 10 copies) containing cloned sequences. Results were calculated as the number of targeted molecules/L cDNA. To standardize results for variability in RNA and cDNA quantity and quality, we expressed the results as the number of target copies per 10 4 copies of ␤-actin gene. The TLR1-10 specific primers and probes were modified from Sha et al. (2) . ␤-actin primer and probes are as follows:
Forward: 5Ј-GGATGCAGAAGGAGATCACTG-3Ј Reverse: 5Ј-CGATCCACACGGAGTACTTG-3Ј Probe: 5Ј-CCCTGGCACCCA GCACAATG-3Ј Flow cytometry analysis. RSV-infected and mock-infected cells (2-3 ϫ 10 5 ) were harvested at 24 h post RSV infection, and stained with PE anti-human Toll-like receptor 4 (Ebioscience, San Diego, CA) for 30 min at 4°C. PE-labeled isotype antibody was used as control. For intracellular staining, cells were fixed with a solution of 3% paraformaldehye in phosphate buffered saline (PBS) for 10 min on ice and permeabilized by incubating a solution of 0.2% Tween 20 in PBS for 15 min at 37°C. Fluorescence analysis was performed using a FACS Calibre machine with the FACScan software.
General LPS stimulation protocol and measurements of IL-6, IL-8, and RANTES by ELISA. In initial experiments, epithelial cells were cultured in RPMI 1640 ϩ 10% FCS, supernatant was collected for IL-8 measurement and cells were harvested for cell count. Within 48 h, IL-8 levels were increased 4-fold in the presence of serum. Therefore, to avoid the confounding effect of serum, cells were maintained in serum-free medium (RPMI 1640) 48 h before infection, and we conducted all the subsequent experiments under serum-free conditions as suggested in previous literature (16) . Briefly, 1 ϫ 10 5 cells were seeded in 24-well plate and grew for 48 h followed by inoculating with RSV for 12 h in serum-free medium. Infected cells were stimulated by 50 g/mL LPS (Escherichia coli, serotype 0111:B4, Sigma Chemical, USA) alone or with 20 g/mL anti-TLR4, HTA125 (AB30667, AbCam, USA) to 48 h. Supernatants were collected, centrifuged at 14,000 rpm for 10 min to remove cell debris, and stored at Ϫ80°C for later analysis of IL-8, IL-6, and RANTES using sensitive ELISA kits obtained from Genzyme (USA) or R&D systems (USA) according to manufacturer's instructions. Concentrations were normalized to pg/mL/10 5 cells. RNA interference in 9HTEo cells. Control nonsilencing siRNA (sense UUCUCCGAACGUGUCACGUTT, antisense ACGUGACACGUUCG-GAGAATT) and siRNA targeting TLR4 (sense CCAGGUGCAUUUAAA-GAAATT, antisense UUUCUUUAAAUGCACCUGGTT) were designed and purchased from Shanghai Benefit Biotechnology Co.LTD. 9HTEo cells were transfected by lipofectamin 2000 according to the manufacturer's protocol (Invitrogen, USA) with 150 nM siRNA per 10 5 cells. (17), constitutively expressed TLR1-10 mRNA. TLR4 and TLR8 mRNA was higher at baseline expression in un-infected 9HTEo cells (Fig. 1A) . All TLRs mRNA were significantly higher after 3 h RSV infection except TLR1 by standard RT-PCR (Table 1) . When infected with RSV for 6 or 9 h, cells presented significant up-regulation of TLR 1-10 mRNA by quantitative PCR, and the pattern in infected cells was characterized by higher levels of TLR4 and TLR8 expression than others (Fig. 1B-K) . The induction of the TLRs mRNA was dependent on viral transcription and replication, as there was no effect observed on cells treated by UV inactivated RSV at the same dose. These data showed that 9HTEo epithelial cells could express TLR1-10 mRNA, and RSV infection has an intensive effect on the epithelial TLRs mRNA expression, especially on TLR4 and TLR8. The observed increase in TLR1-10 mRNA levels by competent RSV priming suggested that RSV might mediate induction of the TLRs mRNA through enhanced mRNA production and/or mRNA stabilization.
RESULTS

TLRs expression pattern in 9HTEo cell
TLR4 protein expression and localization in 9HTEo cell line pre-and postRSV priming. Recent studies have shown that TLR4 of airway epithelial cells is primarily expressed in cytoplasm, and displayed weakly on the cell surface (18) . Therefore, we determined both cytoplasmic and membrane TLR4 protein on un-infected cells by flow cytometry. As expected, TLR4 was mainly detected in the cell cytoplasm, and to a much lesser extent on the surface of cell ( Fig. 2A) . To determine whether the increase of TLR4 mRNA observed by quantitative PCR is translated to protein expression, infected cells were stained with anti-human TLR4 antibody to examine TLR4 surface expression. Fixed and permeabilized cells were used to evaluate changes in cytoplasmic TLR4 expression. Comparable data ( The dynamic shift hypothesis might not entirely explain the remaining 22% of elevated surface TLR4 expression. This TLR4 protein expression pattern from level to localization was caused by RSV, which might be the main reason for the increased percentage of membrane-TLR4 positive cells, consisting with the results we demonstrated above. IL-6, IL-8, and RANTES production in LPS-epithelial system and RSV-epithelial-LPS system. Endotoxin, or its purified derivative LPS, a cell wall component of Gramnegative bacteria, is a potent proinflammatory constituent continuously shedding into the environment, which is important in the pathogenesis of airway inflammatory diseases such as asthma. To study whether LPS-induced cytokine or chemokine production in noninfected airway epithelial cells, we chose chemokine CXC family member IL-8, IL-6 cytokine and the chemokine CCL family member RANTES as examples, as they also play a pivotal role in airway immune response to RSV infection (15, 19) . We found that incubation with 50 g/mL LPS (the dose choosing data were not shown) slightly up-regulated IL-6 production in 9HTEo cells (Fig.  3B) . LPS had no effect on IL-8 or RANTES secretion (Fig. 3A  and C) . Based on our data of TLR4 expression, we hypothesized that the increase of TLR4 expression in RSV-infected cells enhanced the TLR4 signaling triggered by LPS, which might then result in further production of cytokine and chemokine. Data in Figure 3 showed that RSV-infection induced a significant increase of IL-8, IL-6, and RANTES (Fig. 3A, B,  and C) . The concomitant LPS stimulation to RSV-infected cells caused significantly increased IL-8 and IL-6 secretions ( Fig. 3A and B) , suggesting that responsiveness to LPS as proinflammatory stimulation was enhanced in the RSVinfected cells compared with un-infected cells. We proposed that TLR4 might be involved in these responses. Interestingly, we consistently detected the down-regulation of RANTES in RSV-infected cells treated by LPS (Fig. 3C) .
Correlation of TLR4 pathway and IL-8, IL-6, not RANTES secretion profile by LPS in RSV-infected epithelial cells. We further determined the involvement of TLR4 by using HTA125, a TLR4 neutralizing antibody, to observe whether HTA125 could block the effect of LPS on the RSVinfected cells. After stimulation by LPS, RSV-infected cells were incubated with HTA125 for 48 h. Treating the RSV infected cells with HTA125 completely reversed the upregulatory effects of LPS on IL-6 production (Fig. 4B) . The induction of IL-8 production by LPS was only partially reversed, but the decrease was statistically significant (Fig. 4A) . RANTES secretion was not affected by HTA125 incubation (Fig. 4C) . To confirm the involvement of TLR4 in IL-8 and IL-6 secretion, we performed another series of TLR4 targeting RNA interference experiments. First, we evaluated the ability of TLR4-specific siRNA to reduce expression of the corresponding mRNA and protein. After 24 and 48 h transfection, TLR4-specific siRNA clearly inhibited 69.3 and 90.8% TLR4 mRNA expression by quantitative PCR detection, 46 and 78% expression of TLR4 protein by flow cytometry detection, and nonsilencing siRNA failed to inhibit TLR4 mRNA and protein expression (data were not shown). Second, after 24 h TLR4-specific siRNA and control-siRNA transfection, we challenged epithelial cells with RSV and LPS. IL-8 induced by LPS was found to be partially decreased, and IL-6 induced by LPS was almost inhibited in TLR4-siRNA treated epithelial cells, which was similar to HTA125, whereas the controlsiRNA had no effect on IL-8 and IL-6 expression ( Fig. 4D and  E) . Thus, our observations suggested that TLR4 was important for LPS-induced IL-6 and IL-8, not RANTES in RSV-infected epithelial cells. Comparing to mock-infected cells, HTA125 alone had no effect on IL-6 and RANTES secretion, but significantly decreased IL-8 production (Fig. 3A) , which was also investigated in the TLR4-siRNA treated 9HTEo cells (Fig. 4A) . Considering the endotoxin contamination of our system was below 0.25 ng/mL, and serum-free medium was used throughout the ELISA experiments, we supposed that the autocrine IL-8 synthesis of 9HTEo epithelial cell line might be associated with TLR4 pathway.
DISCUSSION
The impact of RSV on epithelial TLRs expression in previous studies only discussed TLR4 and TLR3, which are implicated in the RSV infection by recognition of RSV-F protein and double-stranded RNA, respectively (13, 20, and 21). To the best of our knowledge, this is the first study to demonstrate that TLR1-10 mRNA expressions of 9HTEo epithelial cell could be up-regulated by RSV in a short phase of infection, and that the pattern was characterized by the higher mRNA expression of TLR4 and TLR8. Although TLR4 and TLR8 mRNA was higher at baseline expression in un-infected 9HTEo cells, we proposed the marked changes of these two TLRs might also be attributed to their sensing of RSV-F protein and ssRNA in the presence of RSV replication. The virus replication event was indispensable for its regulation of TLRs expression, and might be explained by the mimic effect of numerous viral intermediate products as TLRs agonists during RSV replication. The up-regulation of the whole TLRs system in virus-primed epithelial cells without exact PAMP recognition might not only mean a start of disastrous inflammatory cascades by these TLRs signaling in RSV infection alone, but may also cause long-term inflammation if some PAMPs stimulated these abnormally sensitive epithelial cells through TLRs pathway at a precise time. It is suggested by the observation that enhanced IL-8 production was found in RSV-challenged A549 cells after LPS and polyriboinosinic:polyribocytidylic acid (polyIC) simulations (20, 21) . However, not all the TLRs pathways could be functional because other reports have shown that RSV-infected A549 cells have no IL-8 response to single-stranded RNA and CpG DNA stimulation (21, 22) . Further, studies are needed to identify the function of these enhanced TLRs pathways.
TLR4 protein was identified as the recognition receptor of LPS and RSV F protein (5) . Several authors examined the inflammatory role of TLR4 signaling in RSV infection through in vivo and in vitro experimental models, and two articles validated the presence of TLR4 on cell surface using flow cytometry. Gagro et al. (23) showed that TLR4 expression on CD14 ϩ monocyte was significantly higher in infants with RSV bronchiolitis. Monick et al. (13) showed that lung alveolar type II epithelial cell line A549 infected by RSV was more sensitive to endotoxin exposure because of the RSV mediated up-regulation of TLR4 protein membrane expression. Herein, we used 9HTEo, another epithelial cell line that originated from human tracheal epithelial cells, to investigate the capability of RSV on TLR4 protein. The distribution of TLR4 protein on 9HTEo cells was mainly in the cytoplasm with little expression on the cell-surface membrane, consistent with previous observations in other epithelial cell line or primary epithelial culture (12) . In RSV-infected epithelial cells, there was moderate TLR4 up-regulation on cell surfaces and corresponding down-regulation in the cellular cytoplasm. We proposed that the increasing surface expression of TLR4 protein was due to TLR4 protein redistribution from cytoplasm to membrane and elevated TLR4 mRNA transcription. Our study further confirmed the up-regulation of TLR4 expression on epithelial cell surfaces by RSV and was the first to show the altered cytosolic location of epithelial TLR4 subse- quent to RSV infection. Surface TLR4 changes by RSV might be functional to render infected-epithelial cells sensitive to TLR4 agonist LPS stimulation. Compared with Monick's protocol, we not only evaluated whether RSV-induced epithelial cells could respond to LPS stimulation as his group did, but also explored what kind of cytokine-chemokine secretion profile RSV-infected cells might display, such as IL-6, IL-8, and RANTES, which are major mediators correlated with the severity of RSV disease (24) . In our studies, LPS as a TLR4 agonist induced higher secretions of IL-6 and IL-8, and decreased RANTES production in RSV-infected epithelial cells. A similar IL-8 response has been reported in RSV priming-A549 epithelial cells, and IL-6 response in infected epithelial cells was similarly observed in LPS-activated monocytes (13, 25) . RANTES secretion of infected epithelial cells was distinct from IL-6 and IL-8. LPS stimulation could not trigger RANTES release as it did in monocytes; in fact, it acted conversely as a glucocorticoid to decrease the RANTES expression. The molecular mechanism, for this different phenotype, was not clear, but might be associated with the interfering role of RSV NS protein in interferon regulatory factor-3 (IRF-3) activation, and needs to be further explored in desirable models (26, 27) .
Besides TLR4, recognition of LPS is associated with non-TLR-related molecules, ranging from integrins such as CD11b/CD18 to chemokine receptors, scavenger receptors, and many others (28) . Through TLR4-blocking and TLR4-specific RNA interference experiments, we found that TLR4 was necessary for the elevation of IL-6 and partial IL-8 in epithelial cells. This suggested that the TLR4 signaling pathway might participate in the IL-6 production of epithelial cells after RSV infection. Kurt-Jones et al. (5) have reported suppressed IL-6 response in macrophages derived from TLR-4 deficient C57BL10/ScCr mice to RSV challenge. Our data suggested a similar role for TLR4 in epithelial IL-6 response to RSV infection. IL-6 is involved in exacerbation of polymorphonuclear neutrophil leukocyte (PMN)-mediated hyperinflammation by delaying PMN apoptosis, and recently, studies descrbied that dendritic cell (DC)-derived IL-6 is necessary for the blockade of regulatory T cell (Treg) activity (29 -31) . So IL-6 induced by epithelial TLR4 pathway is thought to render neutrophil survival, oxidation activity, even inhibition of Treg suppression function, to cause a polarized Th2 response during the infection, all of which would contribute to a long-term inflammatory situation in the RSV disease.
Regarding allergy development, LPS was associated with an increased risk of persistent wheeze during the first year of life, when the incidence of RSV infection was highest (32) . We proposed that the cytokine-chemokine secretion profile played an important role in the positive association of LPS with persistent wheezing. Our results suggest that the profile of cytokine and chemokine released by epithelial cells was different between the RSV alone versus the RSV-allergen cooperative condition. A different secretion pattern could influence immune cell types trafficking to inflammatory sites, and the ability of some resident cells to induce a different inflammatory response. This may potentially cause current wheezing or create a different immunologic memory to contribute to the risk of RAD. In light of our results, it would be particularly interesting to determine what other cytokine and chemokine TLR4 signaling might induce in RSV infection. Studies determining whether TLR4 polymorphisms is related to the RAD post-RSV bronchiolitis would no doubt be a better way to evaluate our hypothesis that TLR4-mediated inflammatory mediator profile was one of the important factors to the clinical outcome.
In summary, our findings provided evidence that RSV up-regulated TLR1-10 mRNA, and TLR4 played an important role in the IL-6 response of airway epithelial cell in an RSV-LPS cooperative system. Further efforts also need to confirm what other T helper-related cytokine productions are induced by TLR4 signaling, and each contribution to clinical consequences for the purpose of effectible therapeutics for RSV-induced RAD.
